Nigerian Propolis Improves Blood Glucose, Glycated Hemoglobin A1c, Very Low-density Lipoprotein, and High-density Lipoprotein Levels in Rat Models of Diabetes

Overview

Journal J Intercult Ethnopharmacol

Date 2016 Jul 2

PMID 27366348

Citations 11

Authors

Mustafa Ibrahim Oladayo

Affiliations

Soon will be listed here.

Abstract

Objective: According to our previous studies, propolis of Nigerian origin showed some evidence of hypoglycemic and hypolipidemic activities in addition to its ability to ameliorate oxidative-stress-induced organ dysfunction. This study was carried out to determine whether an ethanolic extract of Nigerian propolis (EENP) improves glycated hemoglobin A1c (HbA1c), fasting plasma glucose, very low-density lipoprotein (VLDL), and high-density lipoprotein (HDL) concentrations in rats that have alloxan diabetes.

Materials And Methods: Diabetes was induced with alloxan (110 mg/kg). Animals were divided into 5 groups (n = 5); Group 1 was non-diabetic receiving normal saline and Group 2 was diabetic but also received only normal saline. Groups 3, 4, and 5 were diabetic receiving 200 mg/kg propolis, 300 mg/kg propolis, and 150 mg/kg metformin, respectively, for 42 days.

Results: Hyperglycemia, elevated serum level of VLDL, elevated plasma level of HbA1c, and decreased levels of HDL were observed in the diabetic untreated animals. Nigerian propolis decreased blood glucose level and serum level of VLDL but elevated HDL level. These changes were significant (P < 0.05). The levels of plasma HbA1c were also reduced in the propolis-treated groups, and the reduction was significant (P < 0.05).

Conclusion: Nigerian propolis contains compounds exhibiting hypoglycemic, antihyperlipidemic, and HbA1c reducing activities.

Citing Articles

Antifungal Activity of Mexican Propolis on Clinical Isolates of Species.

Rivera-Yanez C, Ruiz-Hurtado P, Reyes-Reali J, Mendoza-Ramos M, Vargas-Diaz M, Hernandez-Sanchez K Molecules. 2022; 27(17).

PMID: 36080417 PMC: 9457601. DOI: 10.3390/molecules27175651.

Effects of Bee Propolis on FBG, HbA1c, and Insulin Resistance in Healthy Volunteers.

Alassaf F, Jasim M, Alfahad M, Qazzaz M, Abed M, Thanoon I Turk J Pharm Sci. 2021; 18(4):405-409.

PMID: 34496480 PMC: 8430402. DOI: 10.4274/tjps.galenos.2020.50024.

Biomedical Properties of Propolis on Diverse Chronic Diseases and Its Potential Applications and Health Benefits.

Rivera-Yanez N, Rivera-Yanez C, Pozo-Molina G, Mendez-Catala C, Mendez-Cruz A, Nieto-Yanez O Nutrients. 2021; 13(1).

PMID: 33383693 PMC: 7823938. DOI: 10.3390/nu13010078.

Molecular and cellular mechanisms of the effects of Propolis in inflammation, oxidative stress and glycemic control in chronic diseases.

Pahlavani N, Malekahmadi M, Firouzi S, Rostami D, Sedaghat A, Bagheri Moghaddam A Nutr Metab (Lond). 2020; 17:65.

PMID: 32817750 PMC: 7425411. DOI: 10.1186/s12986-020-00485-5.

Potential therapeutic effect of Moroccan propolis in hyperglycemia, dyslipidemia, and hepatorenal dysfunction in diabetic rats.

El Menyiy N, Al-Wali N, El Ghouizi A, El-Guendouz S, Salom K, Lyoussi B Iran J Basic Med Sci. 2020; 22(11):1331-1339.

PMID: 32128099 PMC: 7038434. DOI: 10.22038/ijbms.2019.33549.8004.

References

Iwu M, Igboko O, Okunji C, Tempesta M . Antidiabetic and aldose reductase activities of biflavanones of Garcinia kola. J Pharm Pharmacol. 1990; 42(4):290-2. DOI: 10.1111/j.2042-7158.1990.tb05412.x. View

Douillet C, Bost M, Accominotti M, Borson-Chazot F, Ciavatti M . Effect of selenium and vitamin E supplements on tissue lipids, peroxides, and fatty acid distribution in experimental diabetes. Lipids. 1998; 33(4):393-9. DOI: 10.1007/s11745-998-0220-z. View

Zhu W, Li Y, Chen M, Hu F . Protective effects of Chinese and Brazilian propolis treatment against hepatorenal lesion in diabetic rats. Hum Exp Toxicol. 2010; 30(9):1246-55. DOI: 10.1177/0960327110387456. View

Qiu S, Sun H, Zhang A, Xu H, Yan G, Han Y . Natural alkaloids: basic aspects, biological roles, and future perspectives. Chin J Nat Med. 2014; 12(6):401-6. DOI: 10.1016/S1875-5364(14)60063-7. View

Shubrook Jr J, Shubrook J . Risks and benefits of attaining HbA(1c) goals: examining the evidence. J Am Osteopath Assoc. 2010; 110(7 Suppl 7):eS7-12. View

Zamami Y, Takatori S, Koyama T, Goda M, Iwatani Y, Doi S . [Effect of propolis on insulin resistance in fructose-drinking rats]. Yakugaku Zasshi. 2007; 127(12):2065-73. DOI: 10.1248/yakushi.127.2065. View

Sosenko J, Breslow J, Miettinen O, GABBAY K . Hyperglycemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients. N Engl J Med. 1980; 302(12):650-4. DOI: 10.1056/NEJM198003203021202. View

Fuliang H, Hepburn H, Xuan H, Chen M, Daya S, Radloff S . Effects of propolis on blood glucose, blood lipid and free radicals in rats with diabetes mellitus. Pharmacol Res. 2005; 51(2):147-52. DOI: 10.1016/j.phrs.2004.06.011. View

Lenzen S . The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2007; 51(2):216-26. DOI: 10.1007/s00125-007-0886-7. View

10.

Miedema K . Standardization of HbA1c and Optimal Range of Monitoring. Scand J Clin Lab Invest Suppl. 2005; 240:61-72. DOI: 10.1080/00365510500236143. View

11.

Shaw J, Sicree R, Zimmet P . Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2009; 87(1):4-14. DOI: 10.1016/j.diabres.2009.10.007. View

12.

Christov R, Trusheva B, Popova M, Bankova V, Bertrand M . Chemical composition of propolis from Canada, its antiradical activity and plant origin. Nat Prod Res. 2006; 20(6):531-6. DOI: 10.1080/14786410500056918. View

13.

Shi Y, Hu F . The global implications of diabetes and cancer. Lancet. 2014; 383(9933):1947-8. DOI: 10.1016/S0140-6736(14)60886-2. View

14.

Szkudelski T . The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res. 2002; 50(6):537-46. View

15.

Kilpatrick E, Bloomgarden Z, Zimmet P . Is haemoglobin A1c a step forward for diagnosing diabetes?. BMJ. 2009; 339:b4432. DOI: 10.1136/bmj.b4432. View

16.

Bankova V, Popova M, Trusheva B . Propolis volatile compounds: chemical diversity and biological activity: a review. Chem Cent J. 2014; 8:28. PMC: 4014088. DOI: 10.1186/1752-153X-8-28. View

17.

Marquele F, Di Mambro V, Georgetti S, Casagrande R, Valim Y, Fonseca M . Assessment of the antioxidant activities of Brazilian extracts of propolis alone and in topical pharmaceutical formulations. J Pharm Biomed Anal. 2005; 39(3-4):455-62. DOI: 10.1016/j.jpba.2005.04.004. View

18.

Bhadauria M, Nirala S, Shukla S . Propolis protects CYP 2E1 enzymatic activity and oxidative stress induced by carbon tetrachloride. Mol Cell Biochem. 2007; 302(1-2):215-24. DOI: 10.1007/s11010-007-9443-4. View

19.

Viana M, Moraes R, Fabbrin A, Santos M, Gerchman F . [Assessment and treatment of hyperglycemia in critically ill patients]. Rev Bras Ter Intensiva. 2014; 26(1):71-6. PMC: 4031893. DOI: 10.5935/0103-507x.20140011. View

20.

M El-Sayed E, Abo-Salem O, Aly H, Mansour A . Potential antidiabetic and hypolipidemic effects of propolis extract in streptozotocin-induced diabetic rats. Pak J Pharm Sci. 2009; 22(2):168-74. View